Articles by Randall C Willis

Using omics approaches, researchers digitize the analog world of cell biology

To attack cancer, researchers are tapping evolution’s weapon of choice: the immune system

Physics, chemistry and informatics combine to push life into the 4th dimension

Consensus tends to be lacking as to the dividing line between permissible germline genome modification to treat human disease vs. questionable attempts at human enhancement, and that is something we need to sort out

How the flip of a switch is turning neuroscience on its head

DDNews columnist and Features Editor Randall C Willis weighs in on the contentious issue of vaccination and suggests that both sides of the debate may not have much basis for debate in the truest sense of the word

Lots of genomics data, but how much knowledge?

For all of our improvements in throughput and other technological achievements, it is not clear that we've seen much improvement in the number or quality of drugs being produced, and we certainly haven’t made them less expensive. Maybe we need to ask some better questions about what we're doing, how we're doing it and why.

The Society for Neuroscience (SfN) held the 2014 installment of its annual meeting in mid-November, and DDNews Features Editor Randall C Willis gives us a quick overview of highlights, as does EMD Millipore

After decades of questionable results, are disease models turning a corner?

Is it time for Health Canada to give up on regulation of drugs and medical devices, following the lead of the U.S. FDA on that front and focusing on other public health duties for which it is better equipped?

Off- label prescribing of pharmaceutical products by physicians has a long history and even some notable successes, but the practice also poses many challenges and risks.